Discovery Research Articles
-
Mammalian Expression
5/28/2026
See how a biotechnology company advanced an engineered protein therapeutic while navigating development, regulatory, and scalability challenges.
-
Meet MaruXTM: Setting The Standard For End-To-End Continuous Biomanufacturing
5/13/2026
Continuous biomanufacturing boosts speed, flexibility, and control. Modular automation, intensified processing, and streamlined workflows drive productivity and consistent quality.
-
Integrated Drug Discovery: Hit To PCC In 16 Months
5/8/2026
Accelerate your drug discovery program with integrated, cross-functional expertise that advances promising candidates from hit identification to preclinical development with speed and efficiency.
-
ADC Development Grows More Complex — SPR Insights Bring Clarity
4/14/2026
Explore how real-time kinetic analysis reveals how conjugation, linker chemistry, and drug loading influence antibody–antigen interactions, while enabling sensitive detection of anti-drug antibodies.
-
Mammalian Cell Line Development
3/26/2026
Explores how modern cell line engineering boosts speed, stability, and scalability across biologics, with practical insights to cut risk and improve readiness for downstream development.
-
Protein Degraders: From Discovery To Development
3/17/2026
Leverage integrated platforms for targeted protein degradation and molecular glue solutions, from ligand identification to IND-enabling studies. Advanced screening and structural biology support accelerate discovery.
-
Oligonucleotide CDMO: From Preclinical To Commercial
3/11/2026
See how flexible synthesis platforms, structured CMC strategies, and advanced purification tools boost scalability, control impurities, and strengthen readiness for clinical and commercial oligo programs.
-
ADCs: Overcoming Analytical Challenges In Next-Gen Cancer Therapies
2/24/2026
Antibody-Drug Conjugates (ADCs) represent a revolutionary approach in cancer treatment. But with innovation comes complexity.
-
Empowering The Future Of Medicine
2/23/2026
Accelerate from development to commercialization with scalable manufacturing solutions. Integrated digital systems and expert technical advocacy ensure regulatory excellence and rapid batch release.
-
Monoclonal Antibodies & Antibody-Drug Conjugates
2/18/2026
A clear overview of analytical solutions for mAbs and ADCs, covering structural characterization, potency, genetic QC, stability, and biosafety. Learn how comprehensive testing supports safer, more consistent biologics from early development through commercial release.